ask="3.52"
ask_size="500"
average_daily_volume="39450"
bid="N/A"
bid_size="N/A"
book_value="-0.93"
change="-0.22"
change_from_200_day_moving_average="-0.46"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-2.30"
change_From_52_week_low="1.39"
change_in_percent="-6.45%"
close="3.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-1.26"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.48"
ex_dividend_date="N/A"
float_shares="10398000"
high="3.52"
high_52_weeks="5.49"
last_trade_date="2/28/2017"
last_trade_price="3.19"
last_trade_size="411"
last_trade_time="4:00pm"
low="3.19"
low_52_weeks="1.80"
market_capitalization="75.38M"
moving_average_200_day="3.65"
moving_average_50_day="3.21"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.52"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.54%"
percent_change_from_50_day_moving_average="-0.71%"
percent_change_from_52_week_high="-41.89%"
percent_change_from_52_week_low="+76.84%"
previous_close="3.41"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="35.22"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="1.11"
stock_exchange="NGM"
symbol="ONS"
volume="18210"
weeks_range_52="1.80 - 5.49"
